Member News

Spriggs to start lab; Cejka joins EMBO

ASBMB Today Staff
Aug. 2, 2021

Spriggs to start lab at University of Michigan

Chelsey Spriggs, a postdoctoral researcher in the department of cell and developmental biology at the University of Michigan Medical School, has accepted a job as assistant professor in that department. She will begin her lab in 2022.

Chelsey Spriggs

Spriggs, a virologist, is currently a postdoc in Billy Tsai’s lab, studying polyomavirus trafficking. In her most recent publication, she described an unexpected link between viral escape from the secretory pathway into the cytosol and the disassembly of its capsid to let it invade the nucleus.

She is a member of the American Society for Biochemistry and Molecular Biology’s first class of MOSAIC scholars. MOSAIC, which stands for Maximizing Opportunities for Scientific and Academic Independent Careers, is a networking and career development program that supports a cohort of K99/R00 grant recipients as they transition from postdoctoral research into faculty positions.

Spriggs was a leader of the inaugural Black in Microbiology week; she and her co-organizers recently published an account of how that project launched the Black Microbiologists Association. She earned her Ph.D. at Northwestern University studying how human papillomavirus infection leads to tumorigenesis, and her bachelor’s degree at Michigan State University.

Cejka joins EMBO

The European Molecular Biology Organization, or EMBO, has announced the election of 64 new life scientists to its ranks. One of the new members is Petr Cejka, a group leader at the Institute for Research in Biomedicine in Bellinzona, Switzerland, and a professor at the Università della Svizzera italiana.

Petr Cejka

In his lab, Cejka studies homologous recombination as a mechanism for repairing double-stranded DNA breaks. Homologous repair pathways, which use the second, homologous copy of a damaged region to restore the broken section, are important for maintaining genome integrity and are involved in meiotic recombination and some types of genome editing. His team focuses on the earliest steps in the recombination pathway, when DNA around the break site is trimmed back to enable strand exchange proteins to bind. Cjeka's team also studies proteins that separate Holliday junctions, hybrid DNA structures formed during recombination, back into separate DNA strands.

Cejka received the Ernst T. Jucker Award for basic cancer research from the eponymous foundation in 2015 and the Friedrich Miescher Award for Swiss biochemists under 40 in 2017.

Before coming to work at the Institute for Research in Biomedicine in 2016, Cejka was a professor at the University of Zurich. He earned his Ph.D. at the University of Zurich, studying DNA mismatch repair, and conducted postdoctoral research in double-strand break repair at the University of California, Davis.

EMBO’s goal is to promote research in life science and enable international exchange between scientists. The organization has over 1,800 members, who nominate and elect new members annually.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Feature

ASBMB undergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.

Honors for Gagna and Sundquist
Member News

Honors for Gagna and Sundquist

July 7, 2025

Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.